1. The role of aberrant DNA methylation in cancer initiation and clinical impacts
   Franziska Geissler et al, 2024, Therapeutic Advances in Medical Oncology CrossRef
2. A novel prognostic model based on six methylation-driven genes predicts overall survival for patients with clear cell renal cell carcinoma
   Hongmin Zhou et al, 2022, Frontiers in Genetics CrossRef
3. LKB1 biology: assessing the therapeutic relevancy of LKB1 inhibitors
   Charles B. Trelford et al, 2024, Cell Communication and Signaling CrossRef
4. Negative Regulation of Serine Threonine Kinase 11 (STK11) through miR-100 in Head and Neck Cancer
   Gabriela Figueroa-González et al, 2020, Genes CrossRef
5. LKB1 Loss Correlates with STING Loss and, in Cooperation with β-Catenin Membranous Loss, Indicates Poor Prognosis in Patients with Operable Non-Small Cell Lung Cancer
   Eleni D. Lagoudaki et al, 2024, Cancers CrossRef
6. STK11/LKB1 Modulation of the Immune Response in Lung Cancer: From Biology to Therapeutic Impact
   Elvire Pons-Tostivint et al, 2021, Cells CrossRef